Cookies are disabled so parts of this website may not function correctly, read more about cookies and how to enable them here  

Become a member

To apply for SBNS membership click the link below and visit our application page.

Find out more

Patient Information

SBNS is unable to give medical advice or recommend neurosurgeons. Please use an appropriate support group or your GP.

Find out more

Become a Neurosurgeon

The management of neurosurgical patients requires excellent medical and surgical skills, a career in Neurosurgery offers many challenges and rewards.

Find out more

 

PRELIMINARY PROGRAMME  pdf_icon.gif  

As at 10 September  2020 

Please note this programme is subject to minor changes - please check this page on a regular basis in the lead up to the meeting

FRIDAY 23 OCTOBER

09:45
   

 WELCOME
 Alistair Jenkins, SBNS President 

10:00 SESSION 1 - UK MULTI-CENTRE CLINICAL TRIALS: ARE THEY PRACTICE CHANGING?
 

Chairs:
Michael Jenkinson,  Professor of Neurosurgery , The Walton Centre NHS Trust, Liverpool, UK
Sophie Camp, Consultant Neurosurgeon Imperial College Healthcare NHS Trust, London, UK

10:00


NERVES – Results of the Trial
Martin Wilby, Consultant Neurosurgeon, The Walton Centre NHS Trust, Liverpool, UK

10:30

DISCUSISON /INTERACTIVE VOITING  - All Delegates

10:35

 

 

DexCSDH – Results of the Trial
Peter Hutchinson, Professor of Neurosurgery, Addenbrookes’ Hospital, Cambridge, UK
Ellie Edlmann, Clinical Lecturer in Neurosurgery, Plymouth Hospitals NHS Trust, Plymouth, UK
Angelos Kolias, Clinical Lecturer in Neurosurgery , Addenbrookes’ Hospital, Cambridge, UK

11:05 

Discussion/Interactive Voting - All Delegates

11:10 Launch of new NIHR Multicentre Trials
  MAST
Peter Hutchinson, Professor of Neurosurgery, Addenbrookes’ Hospital, Cambridge, UK 
  STOP’EM 
Michael Jenkinson, Professor of Neurosurgery, The Walton Centre NHS Trust, Liverpool, UK
 

CARE
Rustam Al-Shahi Salman, Professor of Clinical Neurology, Edinburgh Royal Infirmary, Edinburgh, UK

11:30 SESSION 2 – ONCOLOGY 
 

Chairs
Puneet Plaha, Consultant Neurosurgeon, John Radcliffe Hospital, Oxford 
Anil Varma, Consultant James Cook University Hospital, Middlesbrough 

11:30


GUEST SPEAKER
S
urgery for new and recurrent gliomas: how much makes sense?
Professor Phillipe Schucht, Head of Neurosurgical Oncology, University Hospital Bern, Switzerland

12:00 ABSTRACTS

12:00


Redo craniotomy or Bevacizumab for symptomatic steroid refractory true or pseudo progression following IMRT for Glioblastoma
M. Black, Northern Sydney Cancer Centre, Sydney, Australia

12:08


Accuracy of Perfusion-MRI in differentiating treatment-related change and tumour progression in post-resected glioblastoma
C. Murphy, King's College NHS Foundation Trust, London, UK

12:16


Longitudinal white matter damage association with sustained attention deficits after surgical glioblastoma resection
J. Van Helden, Addenbrooke's Hospital, Cambridge, UK

12:24  

DISCUSSION/INTERACTIVE VOTING - All Delegates

  GUEST SPEAKER

12:35


Medical Problems of Musical Masters
Phillip L. Pearl, MD, President, Child Neurology Society, Director of Epilepsy and Clinical Neurophysiology, William G. Lennox Chair,  Boston Children's Hospital, USA

13:00

LUNCH BREAK
 

 14:00

SESSION 3 – CRANIAL RECONSTRUCTION

 

Chairs
Mark Wilson, Professor  of Brain Injury, Imperial College Hospitals, London 

14:00



GUEST SPEAKER 
Penetrating Brain & Spine Injuries
Brad Harrington, Consultant Neurosurgeon. Stellenbosch and Tygerberg Academic Hospital. Cape Town, South Africa

14:20 ABSTRACTS

14.20

The UK Cranioplasty Study and Development of the UK Cranial Reconstruction Registry
D. Fountain, Salford Royal NHS Foundation Trust, Manchester, UK

14:28


5-Year Institutional Retrospective Case Series of Decompressive Craniectomy for Malignant Middle Cerebral Artery Infarction (MCAI) (2005-2020)
S. Lammy, Institute of Neurological Sciences, Glasgow, UK 


  GUEST SPEAKER

14:36

As if we didn’t have enough problems: Covid -19 hits South Africa  
Grahame Feiggen, Professor of Neurosurgery
, Neurosciences Institute University of Cape Town

15:00

COFFEE BREAK

 15:30

SESSION 4 – IMPACT OF COVID-19 ON UK NEUROSURGERY

  Chairs
Katie Gilkes, Consultant Neruosurgeon, The Walton Centre NHS Trust, Liverpool, UK
Christos Tolias, Consulant Neurosurgeon, Kings College Hospital, London, UK
 

15:30

IL-Ra COVID-19 Trial
Andrew King, Prof. of Neurosurgery, Salford Royal NHS Foundation Trust, Manchester, UK 
 

15:45


Results of Oncology COVID-19 Trials 
Stephen Price, Consultant Neurosurgeon Addenbrooke's Hospital, Cambridge, UK
Dan Fountain, Salford Royal NHS Foundation Trust, Manchester, UK

16:00

Results of COVID-19 and Pituitary Surgery Survey ; the early days
Nigel Mendoza, Consultant Neurosurgeon, Charing Cross Hospital, London, UK

16:10


How  has Covid-19 impacted on the national neurosurgical waiting list?
(And what can we do about it?)
 Paul Grundy, Consultant Neurosurgeon, University Hospital Southampton,Southampton, UK

16:20

DISCUSSION/INTERACTIVE VOTING All Delegates

  GUEST SPEAKER

6:45


Super-massive Black Holes: Monsters at the heart of galaxies

Sadegh Khochfar, Professor and Chair of Theoretical Astrophysics, University of Edinburgh, Scotland, UK

17:15 

CLOSING REMARKS

 

Alistair Jenkins 
President of the SBNS
 

 

    

 

  

  


          

   

 

 

 

 

 

 

 

 

 


 

Last Updated: 23 September 2020